Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Undifferentiated Pleomorphic Sarcoma
Related studies linked through entity extraction aliases.
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
- Status
- RECRUITING
- Phase
- PHASE2
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas
- Status
- WITHDRAWN
- Phase
- PHASE2
ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
- Status
- RECRUITING
- Phase
- PHASE2
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
- Status
- COMPLETED
- Phase
- PHASE1
Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma
- Status
- RECRUITING
- Phase
- NA
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
- Status
- RECRUITING
- Phase
- NA
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
- Status
- COMPLETED
- Phase
- NA
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- Status
- COMPLETED
- Phase
- PHASE1
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
- Status
- UNKNOWN
- Phase
- PHASE2